Log In
BCIQ
Print this Print this
 

Tango, Tango Nasal

  Manage Alerts
Collapse Summary General Information
Company Karo Pharma AB
DescriptionNasal spray formulation of glucose oxidase
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase II
Standard IndicationViral infection
Indication DetailsTreat rhinovirus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$2.3M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/27/2015

$2.3M

0

0

Get a free BioCentury trial today